Psychotropic Polypharmacy for the Treatment of Bipolar Disorder in Taiwan
Authors:
- Galen Chin-Lun HungGHGalen Chin-Lun Hung
- Shu-Yu YangSYShu-Yu Yang
- Yuefan ChenYCYuefan Chen
- Shih-Ku LinSLShih-Ku Lin
- 1 January 2014
- journal article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 65 (1) , 125-128
Abstract
Psychotropic polypharmacy in the treatment of bipolar disorder has proliferated. Yet evidence about the prevalence and predictors of different combinations of polypharmacy in inpatient settings is scarce. The Nationwide Psychiatric Inpatient Medical Claims (2000-2007) in Taiwan were used to examine prescriptions for mood stabilizers, antipsychotics, and antidepressants among recently discharged patients with bipolar disorder (N=5,449; 51% women, mean±SD age=36.8±12.4). A total of 71% of prescriptions involved between-class polypharmacy, and 17% involved within-class polypharmacy. Patients older than 50 and patients at medical centers (>500 beds) were less likely to receive polypharmacy. Lower prescribed doses predicted polypharmacy. Receiving polypharmacy was not associated with a higher rate of readmission within one year. There was substantial use of various forms of polypharmacy in the treatment of inpatients with bipolar disorder. Randomized studies should be used to compare the cost-effectiveness of common psychotropic combinations and monotherapy to treat bipolar disorder.Keywords
This publication has 12 references indexed in Scilit:
- National Trends in Psychotropic Medication Polypharmacy in Office-Based PsychiatryArchives of General Psychiatry, 2010
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disorders, 2009
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute ManiaThe World Journal of Biological Psychiatry, 2009
- Psychotropic Medications for Patients With Bipolar Disorder in the United States: Polytherapy and AdherencePsychiatric Services, 2008
- Trends in Use of Antipsychotics and Mood Stabilizers Among Medicaid Beneficiaries With Bipolar Disorder, 2001–2004Psychiatric Services, 2008
- Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second‐generation antipsychoticsBipolar Disorders, 2008
- National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in YouthArchives of General Psychiatry, 2007
- Polypharmacy: When Is It Rational?Journal of Psychiatric Practice, 2007
- Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective studyInternational Clinical Psychopharmacology, 2005
- The Increasing Use of Polypharmacotherapy for Refractory Mood DisordersThe Journal of Clinical Psychiatry, 2000